Results 191 to 200 of about 21,293 (203)

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting

AIDS Patient Care and STDs, 2019
Kai Juhani Kauppinen
exaly  

Isolation, LC–MS/MS and 2D-NMR characterization of alkaline degradants of tenofovir disoproxil fumarate

Journal of Pharmaceutical and Biomedical Analysis, 2015
M V N Kumar Talluri
exaly  

Stability behaviour of antiretroviral drugs and their combinations. 4: Characterization of degradation products of tenofovir alafenamide fumarate and comparison of its degradation and stability behaviour with tenofovir disoproxil fumarate

Journal of Pharmaceutical and Biomedical Analysis, 2016
Moolchand Kurmi, Saranjit Singh
exaly  

Tenofovir-disoproxil-fumarate

Reactions Weekly, 2018
openaire   +1 more source

Tenofovir alafenamide for hepatitis B virus infection including switching therapy from tenofovir disoproxil fumarate

Journal of Gastroenterology and Hepatology (Australia), 2019
Shun Kaneko, Masayuki Kurosaki, Nobuharu Tamaki   +2 more
exaly  

Tenofovir disoproxil fumarate

Reactions Weekly, 2007
openaire   +2 more sources

Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B

Gastroenterology, 2012
Anna Lok, William Sievert, David K Wong
exaly  

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Lancet, The, 2012
exaly  

Pharmacokinetics and Dosing Recommendations of Tenofovir Disoproxil Fumarate in Hepatic or Renal Impairment

Clinical Pharmacokinetics, 2012
exaly  

Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers

British Journal of Clinical Pharmacology, 2007
exaly